Driving forward our UK science innovation companies for city economy
How does the UK support young science companies to grow and succeed in a globally competitive environment, where firms have the potential to create the next medical breakthrough? Furthermore, what is the right physical environment in which these science companies can thrive and connect with larger organisations, such as teaching hospitals?
As a follow-up to our Cambridge forum, where we looked at the growth of science innovation and the design of urban knowledge hubs, we are holding a round table discussion this week to try to answer these questions.
Among contributors are Peter Ward, Director of Real Estate Development, King's College, London and Guys' and St Thomas' NHS Foundation Trust, and a medical diagnostics company incubated at Imperial College London, called SIME Dx, which is working in the area of neonatal care.